About CH ARRAS
"Le Centre Hospitalier d'Arras est un établissement public de santé proposant une offre de soins de qualité et de proximité en médecine, chirurgie, obstétrique, psychiatrie et gériatrie."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University Hospital, Lille
16
Centre Hospitalier Arras
6
The Lymphoma Academic Research Organisation
4
Lille Catholic University
3
University Hospital, Brest
3
Hoffmann-La Roche
2
Intergroupe Francophone du Myelome
2
ARCAGY/ GINECO GROUP
1
Assistance Publique - Hôpitaux de Paris
1
Biotronik France
1
Celgene
1
Clinical Trials at CH ARRAS
During the past decade, CH ARRAS conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 2 clinical trials were completed, i.e. on
average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
2006-06-21
2015-12-18
Completed
1,993
A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis
2008-09-30
2011-07-31
Completed
96
Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
2009-12-01
2022-06-01
Completed
118
Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM)
2010-07-01
2013-11-01
Completed
602
Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP
2009-04-01
2019-09-01
Completed
650
Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients
2010-12-01
2020-05-23
Completed
650
Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL
2011-05-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CH ARRAS" #1 sponsor was "University Hospital, Lille" with 16 trials, followed by "Centre Hospitalier Arras" with 6 trials
sponsored, "The Lymphoma Academic Research Organisation" with 4 trials sponsored, "Lille Catholic University" with 3 trials sponsored and "University Hospital, Brest"
with 3 trials sponsored. Other sponsors include 20 different institutions and
companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CH ARRAS"
#1 collaborator was "Ministry of Health, France" with 6 trials as a collaborator, "Région Nord-Pas de Calais, France" with 2 trials as a collaborator, "ARAIRLOR" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Air Liquide SA" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were
collaborators in the rest 34 trials.
Clinical Trials Conditions at CH ARRAS
According to Clinical.Site data, the most researched conditions in "CH ARRAS" are
"Alzheimer Disease" (2 trials), "Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Obesity" (2 trials) and "Venous Thromboembolism" (2 trials). Many other conditions were trialed in "CH ARRAS" in a lesser frequency.
Clinical Trials Intervention Types at CH ARRAS
Most popular intervention types in "CH ARRAS" are "Drug" (18 trials), "Other" (15 trials), "Procedure" (5 trials), "Device" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Lenalidomide" (2 trials), "Rituximab" (2 trials), "ABTEST card" (1 trials) and "Air" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CH ARRAS
The vast majority of trials in "CH ARRAS" are
55 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at CH ARRAS
Currently, there are NaN active trials in "CH ARRAS".
2 are not yet recruiting,
15 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 32 completed trials in CH ARRAS,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in CH ARRAS, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 17 trials that are defined as “Not Applicable".